Keywords
hepatitis C virus, viral hepatitis, public health policy, risk factors, sexual transmission, systematic review
hepatitis C virus, viral hepatitis, public health policy, risk factors, sexual transmission, systematic review
Hepatitis C virus (HCV) infection was first identified in 19891. Chronic HCV infection is an important cause of chronic liver disease and liver related death worldwide2 with an estimated 130 to 150 million persons having chronic HCV infection globally3. The prevalence of HCV infection varies across countries and areas4. Of those infected with HCV, many are asymptomatic with approximately 20% to 30% developing acute symptoms5,6 and 55% to 85% developing chronic infection7. Of those who develop chronic infection, 15% to 30% will develop liver cirrhosis within 20 years3. Annually, approximately 3% to 4% of patients with liver cirrhosis develop hepatocellular carcinoma8.
Identification of risk factors associated with HCV transmission is essential in guiding screening and prevention strategies to improve health outcomes and maximise cost-effectiveness. There is currently no effective vaccination for HCV, putting even more emphasis on infection prevention9. Since the introduction of routine screening of blood in the early 1990s, transfusion-related HCV infection is rare. Literature on risk factors for HCV infection indicate that Injecting Drug Use (IDU) is now the main mode of transmission10. Other reported risk factors include occupational exposure, tattooing or having blood transfusions, vertical transmission and sex with an infected partner10.
The role of sexual transmission in HCV transmission is not fully understood and an increasing number of studies examine this question. Some studies found HCV RNA in semen11,12, but other studies have contradicted these findings13,14. Tohme and Holmberg15 conducted a systematic review concerning the risk of HCV sexual transmission. They found that having multiple sexual partners might increase risk of HCV infection, although this finding may be confounded by IDU. Moreover, HIV co-infected individuals and Men who have Sex with Men (MSM) were clearly more at risk. Sexual transmission in people in monogamous heterosexual relationships on the other hand is rare; however, it is uncertain what specific sexual behaviours in heterosexuals do increase the risk of HCV transmission. Since their review was published in 2010, additional studies have emerged and an updated review was required to inform guidance on screening for HCV infection. We also aimed to increase generalisability to the context of low HCV prevalence countries because in high endemic countries there may be other risk factors in the population that make it difficult to identify sexual transmission at the source. Moreover, we focussed on heterosexuals but excluded high risk populations such as people who inject drugs (PWID), prisoners and HIV co-infected people, to address the question of when HCV screening is warranted in a more general population. Subsequently, the aim of this systematic review was to determine what factors, if any, are associated with an increased risk of sexual transmission of HCV infection in a heterosexual population in low HCV prevalence countries. This review was registered in PROSPERO (CRD42016051099).
A comprehensive search of both electronic databases and grey literature was conducted by VL. We searched the following databases up to 4th November 2016, attempting to identify all relevant studies: Medline (OVID), EMBASE (OVID), Science Citation Index-Expanded, Social Sciences Citation index, Conference proceedings (Web of Science), Cinahl (EBSCOHost), Scopus and LILACS (Bireme). We used a combination of controlled vocabulary terms and free-text terms including: Hepatitis C, Hepacivirus, Incidence, Prevalence, Risk-Taking, Risk Factors, Sexually Transmitted Diseases, transmission, Exposure, Sexual Behavior, Sexual Partners. We adapted the queries to each database. We did not limit our searches by time or language. We searched for additional studies by reviewing the reference lists of all included studies, and by using the “Similar articles” function in Medline. For grey literature, we looked at the following websites: WHO (World Health Organization); CDC (Centre for Disease Control and Prevention); ECDC (European Centre for Disease Control and Prevention); BASHH (British Association for Sexual Health & HIV); IUSTI (International Union against Sexually Transmitted Infections); AASLD (American Association for the Study of Liver Diseases); EASL (European Association for the Study of the Liver); Society for the Study of Sexually Transmitted Diseases in Ireland (SSSTDI); American Sexually Transmitted Diseases Association (ASTDA).
More details on the search terms can be found in Figure 1.
The selection criteria were set in Population, Exposure, Outcome, Study design (PEOS) format. The population of interest included heterosexual adults (≥18 years), excluding those with HIV co-infection, PWIDs, homo- or bisexuals, or prisoners, because these populations are at high risk of HCV infection. In addition, this review excluded studies conducted in high HCV prevalence countries, because the aim of this review was to provide guidance for assessing the need of screening specific populations in the setting of low HCV prevalence countries16. The list of high HCV prevalence countries was obtained from the Health Protection Surveillance Centre (Ireland), Infectious disease assessment for migrants17, but the HCV prevalence of Nigeria was changed to high (>3%) following the publication of the epidemiological report on hepatitis C and B by the European Centre for Disease Prevention and Control in August 201616.
The exposure was any sexual behaviour factor including (but not limited to) having multiple sex partners, overlapping (more than one sexual relationship at the same time), changing sexual partners frequently, unprotected sex outside of monogamous relationship (sex acts without the use of a condom), exchange of sex for drugs (but not PWID) or money, being a commercial sex worker, sex with commercial sex workers, sex under the influence of drugs or alcohol, anal sex, having another Sexual Transmitted Infection (STI) (excluding HIV), having a high risk partner (defined as any of the above). The exposure could be self-reported or based on an objective measure e.g. the number of occasions condoms used/not used. The outcome HCV infection had to be determined by antibody/antigen or PCR RNA test, excluding self-reported HCV status.
We included cohort studies, case-control studies and cross-sectional studies, but excluded case studies, case series and reviews. We only included studies published in or after the year 2000 because of the variability in the quality of HCV serological testing in earlier studies.
Records identified in the search were screened independently by title/abstract and then by full-text by at least two reviewers (FW, VS, PF, GG, LM, SS). Conflicts were resolved by FW, VS and PF through discussion, and if necessary by involving another reviewer (DD).
Risk of bias (ROB) in the included studies was assessed by two independent reviewers (FW, JCJ) using the Quality In Prognosis Studies (QUIPS) tool18. The ROB criteria for each QUIPS domain specific to this review, including appropriate methods for HCV infection measurement and important confounders should have been adjusted for, were documents a priori and agreed by all authors. Conflicts were resolved through discussion. A data extraction form was developed and reviewed by all authors. Data extraction was conducted by two reviewers independently (VS, GG, LM and FW). Any conflicts were resolved by a third reviewer (FW).
When only raw data (proportions) were available, we calculated the unadjusted Odds Ratios (OR) and 95% Confidence Intervals (CI) using the natural log scale19. We planned to conduct meta-analyses in Revman20 and to assess statistical heterogeneity (I2 ≥ 50%, T2 > 0, or the p-value > 0.10 for the Chi square test)21. However, it was not appropriate to carry out meta-analysis due to clinical and methodological heterogeneity, and findings are summarised narratively and presented in evidence tables.
The quality of evidence was assessed by two independent reviewers (VS and FW) using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach for prognostic factor research22. This review was reported according to the Meta-analysis of observational studies in epidemiology (MOOSE) guidelines (completed checklist in Supplementary File 1)23.
A total of 10460 records were identified through the database searches. We did not identify any records through the grey literature searches. Two further duplicates were detected and 10458 records were screened by title and abstract, of which 274 were selected as potentially eligible and assessed by full-text. A total of eight studies were finally included.
We contacted the authors to obtain more information to assess eligibility for an additional 11 records in abstract format and these are awaiting classification. Full details of the search results and selection process are presented in Figure 2.
The 8 included studies were published between the year 2000 and 2015, in Mexico (n=2), USA (n=2), Vietnam (n=1), Scotland (n=1), Gambia (n=1), and Brazil (n=1). A total of 14036 participants were included in the eight studies and seven potential sexual risk factors were assessed across the studies. These were multiple sex partners, receiving or providing sex commercially, having a PWID (People who inject drugs) partner, and unprotected vaginal, oral or anal sex.
Only three factors were examined in more than one study. The majority of studies included sample populations from specific groups: one study examined risk factors in a sample of blood donors24, one involved pregnant women attending antenatal services25, one in homeless people26, one in non-PWIDs27, one in nurses28, and one in a sample of different risk groups29. Full details of the characteristics of the included studies are presented in Table 1.
Study (Design) | Setting (Country) | Participant inclusion/exclusion criteria | Risk factors (measurement method) | Outcome measurement |
---|---|---|---|---|
Dunford et al. (2012)31 (Cross-sectional) | Different geographic regions of Vietnam | 8 different population groups including people who inject drugs (PWIDs), commercial sex workers (CSWs), blood donors, military recruits, pregnant women, dialysis patients, elective surgery patients and recipients of multiple blood transfusions.a | Commercial sex worker (unclear) | Enzyme immunoassay (EIA) for HCV using the Monolisa Ag/Ab HCV Ultra (Bio-Rad Laboratories, CA, USA). |
Goldberg et al. (2001)25 (Retrospective) | Ninewells Hospital Dundee; antenatal clinic (Scotland) | All women who were seen at the antenatal clinic and all women who were admitted for termination of pregnancy to the gynaecology wards. | Non-PWID but partner is PWID (Linked dataset information) | Initial screening by Ortho Diagnostics hepatitis C virus 3.0 ELISA Assay. If HCV antibodies identified, retested using Monolisa hepatitis C virus confirmatory testing; only serum samples which were reactive on both tests were considered to be HCV antibody positive. |
Mboto et al. (2005)24 (Cross-sectional) | Royal Victorial Hospital, Banjul (Gambia) | Asymptomatic first-time blood donors. | Polygamous marriage | ELISA assay system for analysis of blood samples. |
Melo et al. (2015)30 (Cross- sectional) | Rural urban area - population 2,640 inhabitants (Brazil) | > 18 years and providing informed consent for interview and blood sampling | ≥6 sexual partners over a lifetime, ≥2 sexual partners over a lifetime (Structured interview questionnaire) | Enzyme immunoassay tests to detect the markers anti-HCV. Qualitative detection of hepatitis C virus- ribonucleic acid (HCV RNA) [Amplicor version 2.0 (Roche)] was performed for the anti-HCV-positive serum or potentially positive serum. |
Mendez-Sanches et al. (2005)29 (Cross-sectional) | University Hospital Check-up unit, Mexico City (Mexico) | Inclusion: people with one of the following risk factors: blood transfusion before 1992; surgeries before 1992; IV drug use as unique risk factors. People with two or more the following risk factors: tattoos, contact with known HCV- infected people; previous manicures or pedicures with a non-personal instrument; dental surgery; piercing; acupuncture; more than three sexual partnersb | More than three sexual partners (Patients were interviewed and completed a questionnaire) | Screened for HCV RNA by qualitative polymerase chain reaction (PCR) using the Cobas Amplicor HCV Test Version 2.0 (Roche Laboratories Ltd., USA). In HCV RNA-positive patients, genotyping was performed using the HCV RNA Genotype Duplitype Assay (Quest Diagnostics, USA). |
Mendez-Sanches et al. (2006)28 (Cross-sectional) | Tertiary-care hospital, Mexico City (Mexico) | All nursing personnel. | More than four Sexual partners (Self-reported questionnaire) | Axsyum HCV system version 3. In positive cases qualitative and quantitative viral load and genotype were assessed through PCR for RNA- HCV. |
Neaigus et al. (2007)27 (Prospective longitudinal) | New York City (USA) | >18 years, had used non-injected heroin during the preceding 30 days, and had either never injected drugs or had not done so during the preceding 6 months. Eligibility tests of urine, hair, body sites, structured screening questionnaire and ethnographic methods were used. | Unprotected vaginal sex, Unprotected anal sex, Unprotected oral sex, Commercial sex received, Commercial sex provided, Multiple sex partners in last 30 months, Sex with PWID (structured interview questionnaire) | HCV antibody tested by HCV EIA 2.0 |
Nyamathi et al. (2002)26 (Cross-sectional but sample derived from a quasi-experimental study) | 36 homeless shelters or sober- living shelters or from street outreach in Los Angeles (USA) | 18–65 years; homeless; having an intimate partner or friend termed an impoverished adult. | Multiple sex partners in last 6 months (No versus yes) (structured questionnaire) | Ortho HCV ELISA Test kit System Version 3.0 |
A total of 266 studies were excluded at full-text selection. Reasons for exclusion included participants under the age of 18 in the sample (n=38), study examined the prevalence of HCV but did not assess risk factors (n=31), and study publication not available in English (n=24), which may have introduced language bias. Many studies examined risk factors other than sexual factors of interest (n=25). Twenty-eight were excluded because of their study design; 24 were narrative reviews, three were systematic reviews, and one study was a case report. Sixty-seven studies included PWIDs, homosexuals and/or (ex-) prisoners in their sample and did not report findings separately for these groups.
Details of the judgment of ROB of each domain for each study are provided in Table 2. Study participation was judged as moderate (n=2) or high (n=6) ROB for all studies. Participants of included studies were specific groups that might have influenced the findings, such as healthy blood donor (n=1), nurses (n=1), pregnant women (n=1), homeless people (n=1). One study had a low recruitment rate30, but other studies did not describe their recruitment rate.
Record | Study participationa | Study attritiona | Factor measurementa | Outcome measurementa | Study confoundinga | Statistical analysis and reportinga |
---|---|---|---|---|---|---|
Dunford et al. (2012)31 | + | - | +/- | - | + | + |
Recruitment not described, no baseline characteristics for all participants. | Cross- sectional study | No clear method of measurement provided. | Enzyme immunoassay (EIA) for HCV using the Monolisa Ag/ Ab HCV Ultra (Bio-Rad Laboratories, CA, USA). | No adjustment for confounders | No multivariable analysis. | |
Goldberg et al. (2001)25 | +/- | - | - | - | + | + |
Selective sample of onlly pregnant women. | Cross- sectional study | Structured questionnaire | Ortho Diagnostics hepatitis C virus 3.0 ELISA Assay (Chiron Corporation, Emeryville, California) | No adjustment for confounders | No multivariable analysis. | |
Mboto et al. (2005)24 | + | - | +/- | - | + | + |
Only healthy blood donors included of which only 2 women. | Cross- sectional study | Interviews not clearly described. | ELISA kit | No adjustment for confounders | No multivariable analysis. | |
Melo et al. (2015)30 | +/- | - | - | - | - | - |
Only 51.9% participation rate | Cross- sectional study | Structured standardised questionnaire | virusribonucleic acid (HCV RNA) [Amplicor version 2.0 (Roche)] was performed for the anti-HCV-positive serum or potentially positive serum. Virusribonucleic acid (HCV RNA) [Amplicor version 2.0 (Roche)] was performed for the anti-HCV-positive serum or potentially positive serum. | Adjustment for confounders | Multivariable analysis. Clearly reported. | |
Mendez-Sanches et al. (2005)29 | + | - | - | - | + | + |
Only includes participants who report certain risk factors | Cross- sectional study | structured questionnaire | Qualitative polymerase chain reaction (PCR) using the Cobas Amplicor HCV Test Version 2.0 (Roche Laboratories Ltd., USA). HCV RNA-positive serum was also screened by quantitative PCR using the Cobas Amplicor HCV Test Version 2.0(Roche Laboratories Ltd) with a dynamic range lower limit of 50 IU/mL. In HCV RNA-positive patients, genotyping was performed using the HCV RNA Genotype Duplitype Assay (Quest Diagnostics, USA), a DNA sequencing technology to subtype two regions of the HCV genome:the CORE gene and the NS5B region. | No adjustment for confounders | No multivariable analysis. | |
Mendez-Sanches et al. (2006)28 | + | - | - | - | - | + |
Only nurses included | Cross- sectional study | Structured questionnaire | Axsyum HCV system version 3 | Adjustment for confounders | Multivariable analysis but not clearly reported. | |
Neaigus et al. (2007)27 | + | + | - | - | - | - |
Only (non-intravenous) drug users | Only 62.2% retention rate. | Structured interview | HCV EIA 2.0 (Abbott) | Adjusted for important confounders | Multivariable analysis and clearly reported. | |
Nyamathi et al. (2002)12 | + | - | - | - | +/- | +/- |
Only homeless people included. | Cross- sectional study | structured questionnaire | ELISA kit | Adjusted for gender, age, age started living on their own, daily alcohol use but not adjusted for tattoo/ body piercing | Clearly presented and multivariable analysis but key confounders not included. |
Seven of the 8 included studies were cross-sectional studies, hence there was low attrition bias. Only Neaigus et al.27 followed up patients and had a low retention rate of only 62.2%, leading to high risk of attrition bias. Six of the 8 studies were judged as low ROB for the domain risk factor measurement as the risk factor was measured using a structure questionnaire. Two studies were of moderate ROB because they did not provide a clear description of risk factor measurement.
All studies appropriately assessed the outcome HCV infection, most commonly using the ELISA kit, and were thus judged as low ROB. Four studies did not adjust for confounders and were therefore judged as high ROB for this domain. Nyamathi et al.26 adjusted for confounders but did not include some important confounders such as a history of tattooing and was judged as moderate ROB. The remaining three studies were judged low ROB. Four studies did not conduct multivariable analysis to adjust for confounders and hence were rated as high ROB for statistical analysis. Nyamathi et al.26 adjusted for some confounders (gender, age, age started living on their own, daily alcohol use) but not all important ones (e.g. tattooing/body piercing) were included in the model; hence this study was rated as moderate ROB.
A total of seven potential risk factors were examined in the eight included studies. Evidence for all factors was of very low quality and full details of the GRADE profiles by factor are provided in Table 3.
Potential risk factor identified | No. of participants | Reference(s) & phase of investigation | No. of studies | Univariate | Multivariate | Dominant Phase** | GRADE factorsk | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
+ | 0 | - | + | 0 | - | Study limitations | Inconsistency | Indirectness | Imprecision | Publication bias | Moderate/ large effect size | Dose effect | Overall qualityh | |||||
Multiple sex partners | 2884 | Neaigus et al. (2007) (Phase 1)i Nyamathi et al. (2002) (Phase 1)j Melo et al. (2015) (Phase 1)i Mendez-Sanchez et al. (2005) (Phase 1)i Mendez-Sanchez et al. (2006) (Phase 1)i Mboto et al. (2005) (Phase 1)i | 6 | 0 | 6 | 0 | 0 | 1 | 0 | 1 | xa | v | v | xb | v | v | v | + |
Commercial sex work | 7931 | Dunford et al. (2012) (Phase 1)i Neaigus et al. (2007) (Phase 1)i | 2 | 0 | 2g | 0 | 0 | 0 | 0 | 1 | xxc | xd | v | xb | xd | v | v | + |
History of sex with CSW | 277 | Neaigus et al. (2007) (Phase 1)i | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | xxc | v | v | xb | xd | v | v | + |
Partner who is an IDU | 3775 | Neaigus et al. (2007) (Phase 1)i Goldberg et al. (2001) (Phase 1)i | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | xf | xe | v | xb | xd | v | v | + |
Unprotected vaginal sex | 277 | Neaigus et al. (2007) (Phase 1)i | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | xf | xd | v | v | xd | v | v | + |
Unprotected anal sex | 277 | Neaigus et al. (2007) (Phase 1)i | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | xf | xd | v | v | xd | v | v | + |
Unprotected oral sex | 277 | Neaigus et al. (2007) (Phase 1)i | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | xf | xd | v | v | xd | v | v | + |
a Downgraded by one level because seven of the eight studies had at least one domain high ROB or two domains moderate ROB; b Downgraded by one level because some studies have wide confidence intervals and no power calculations provided; c Downgraded two levels since the study has more than 1 domain high ROB or two moderate; d Downgraded by one level because only one or two study(ies) has(ve) provided an effect estimate; e Downgraded by one level because the confidence intervals do not overlap; f Downgraded by one level because of a study has more than 1 domain high ROB or two moderate; g For one of the two studies the effect could not be estimated and was subsequently classified as no effect; h GRADE levels of evidence: + very low, ++ low, +++ moderate, ++++ high quality; i Phase 1 of investigation (Hayden 2008), conducted only univariate analysis for the factor of interest; j Phase 1 of investigation (Hayden 2008), multivariable analysis but no specific hypotheses tested; k Explanation of symbols: ‘v’ not downgraded/upgraded, ‘x’ downgraded/upgraded by one level, ‘xx’ downgraded/upgraded by two levels.
Six studies examined having had multiple sex partners as a potential risk factor for HCV infection (Table 4). Different cut-offs and analysis methods did not allow us to pool data in meta-analysis. Only one study adjusted for confounders and did not find having more than three sex partners in the last six months to be a significant risk factor26. Similarly, the other five studies did not find a positive association. However, evidence should be interpreted with caution since the quality of evidence (GRADE) is very low.
Factor | Study | No of participants in analysis | Risk estimate (unadjusted) | Adjusted risk estimate | Confounders adjusted for |
---|---|---|---|---|---|
Multiple sex partners in the last 30 months | Neaigus et al. (2007)27 | 277 | ORa 0.9 (0.4–2.1), p=0.8 | /b | N/A |
> 3 sex partners in last 6 months (No versus yes) | Nyamathi et al. (2002)26 | 743 non- injection drug user samples | OR 0.2 (0.03 to 1.5) | AOR 0.14 (0.02 to 1.06) | Gender, age, ethnicity, age started living alone, recent daily alcohol use. |
≥ 2 sexual partners over a lifetime | Melo et al. (2015)30 | 1001 | One (0.1%) case of confirmed HCV infection. This man denied blood transfusion, He reported no more than 5 sexual partners over a lifetime or 2 partners in the last 6 months. | /b | N/A |
> 3 sexual partners | Mendez- Sanchez, et al. (2005)29 | 300 | ORa 1.6 (0.3–8.1), p=0.6 | /b | N/A |
> 4 sexual partners | Mendez- Sanchez, et al. (2006)28 | 376 | ORa 1.5 (0.08–29.7), p=0.8 | Not included in multivariable analysis due to insignificant in univariate analysis. | N/A |
≥ 6 sexual partners over a lifetime | Melo et al. (2015)30 | 1001 | One (0.1%) case of confirmed HCV infection. This man denied blood transfusion, He reported no more than 5 sexual partners over a lifetime or 2 partners in the last 6 months. | /b | N/A |
Polygamous marriage (vs monogamous marriage) | Mboto et al. (2005)24 | 187 | OR 2.6 (0.24–27.8) | /b | N/A |
aCalculated from raw data (95% CI calculated using natural logarithm method19.
Evidence of being a commercial sex worker as a risk factor for HCV infection was limited (measured in 2 studies only27,31) and of very low quality (GRADE). Dunford et al.31 found that 8.7% of commercial sex workers were HCV positive, and of those 40.2% (n=87) were non-PWIDs, but did not report data on the comparison group (non-PWID CSWs negative for HCV). Neaigus et al.27 found a positive effect but it was not statistically significant (unadjusted OR 2.0 (0.6-6.7); p=0.3; n=277).
A history of having sex with a commercial sex worker was not associated with HCV infection (unadjusted OR 1.9 (0.5-8.0), p=0.4; Male: HR 4.1 (0.91–18.0); Female: not reported; n=277; one study), but the quality of evidence (GRADE) was very low due to only one study examining this factor with significant risk of bias27.
There was conflicting evidence regarding the role of having a partner who is a PWID as a risk factor for HCV infection and quality of evidence was very low due to significant ROB and a limited number of studies examining this factor. Goldberg et al.25 found that having a PWID partner was a significant risk factor (unadjusted OR 56.6 (18.5 -173.60), p<0.0001; n=3498), but Neaigus et al.27 found no association (unadjusted OR 1.2 (0.3 –5.2); n=277).
In one study (n=277), unprotected vaginal sex (unadjusted OR 1.5 (0.8–2.7), p=0.2; Males: Hazard Ratio (HR) 0.75 (0.25–2.3); Females: HR 0.49 (0.11–2.3)), unprotected anal sex (unadjusted OR 0.8 (0.2–3.1), p=0.8; Females: HR 1.7 (0.22–12.8); Male: not reported), and unprotected oral sex (unadjusted OR 0.7 (0.4–1.3), 0.2; Females: HR 0.93 (0.21–12.8); Male: not reported) were not associated with HCV infection (very low quality evidence)27.
Seven potential sexual risk factors for HCV transmission in a heterosexual population were examined in eight studies, including multiple sex partners, receiving or providing sex commercially, having a PWID partner, and unprotected vaginal, oral or anal sex. None of these factors were statistically significant risk factors in the included studies; however, we are uncertain about these results due to the very low quality of evidence (GRADE). Moreover, these results might have been affected by a potential lack of statistical power and none of the studies provided sample/power calculations. Goldberg et al.25 did find that having a sex partner who is a PWID was associated with an increased risk of HCV infection resulting in conflicting evidence because the other study examining this factor did not find a significant association27. Goldberg et al.25 was conducted in Scotland, which might provide more geographically relevant information as this is a similar context to Ireland and other European countries. However, being a partner of a PWID could also expose people to non-sexual HCV transmission and may have confounded this finding.
Evidence for all factors examined in the included studies was of very low quality, mainly due to a lack of replication and high ROB resulting from a lack of adjusting for confounders and selective samples. Incomplete or non-standardised measurement of sex practices in some of the included studies could also have impacted on the findings of this review. Moreover, only seven factors were examined in the included studies and other factors such as use of condom, sex during menses, rough sex, presence of other STIs etc., were not measured and assessed. Even though we excluded studies that examined PWIDs, subjects may not disclose being a PWID, particularly since data on factors was generally obtained through a self-reported questionnaire.
The strengths of this review lie in its comprehensive search, its double independent study selection, ROB assessment, data extraction and GRADE quality assessment.
This review adhered to the a priori selection criteria set and excluded any study that included PWIDs, prisoners and/or homo- or bisexuals in their sample in the absence of subgroup analyses for these groups. This approach limited the number of included studies. A more liberal approach to review study inclusion criteria (i.e. including the 67 studies that partly included these groups) might be useful in further addressing the objective of this review. However, caution should be had when doing so to avoid the impact of confounders on the findings and we would recommend conducting subgroup analyses in such case.
All data underlying the results are available as part of the article and no additional source data are required.
FW and DD designed the protocol with input from all authors. VL constructed and conducted the search. All authors reviewed the search. FW, VS, PF, SS, LM, GG conducted study selection and data extraction. FW and JCJ conducted the ROB assessment. FW and VS conducted the GRADE quality assessment. FW drafted the manuscript. All authors were involved in the data interpretation and reviewed the manuscript.
The National University of Ireland Galway received payment for the conduct of this research from the National Clinical Effectiveness Committee of the Department of Health (Ireland) who commissioned this work.
VL’s institution received payment from the National University of Ireland Galway to conduct the search for this review.
This work was supported by the Clinical Effectiveness Unit of the Department of Health (Ireland).
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
We thank the Steering Group for this project for their insight and support through the conduct of this work. We would like to thank Dr Rania Tohme (Centers for Disease Control, Atlanta, USA) for providing expert advice for this review.
Are the rationale for, and objectives of, the Systematic Review clearly stated?
Yes
Are sufficient details of the methods and analysis provided to allow replication by others?
Yes
Is the statistical analysis and its interpretation appropriate?
Yes
Are the conclusions drawn adequately supported by the results presented in the review?
Yes
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: I am a Fellow in the American College of Epidemiology. A tenured full professor in the John A Burns School of Medicine. I have published significant studies on the epidemiology of HCV.
Are the rationale for, and objectives of, the Systematic Review clearly stated?
Yes
Are sufficient details of the methods and analysis provided to allow replication by others?
Yes
Is the statistical analysis and its interpretation appropriate?
Yes
Are the conclusions drawn adequately supported by the results presented in the review?
Yes
Competing Interests: No competing interests were disclosed.
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | ||
---|---|---|
1 | 2 | |
Version 1 08 Mar 18 |
read | read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Register with HRB Open Research
Already registered? Sign in
Submission to HRB Open Research is open to all HRB grantholders or people working on a HRB-funded/co-funded grant on or since 1 January 2017. Sign up for information about developments, publishing and publications from HRB Open Research.
We'll keep you updated on any major new updates to HRB Open Research
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)